These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 1531070)
1. Myocardial distribution of indium-111-antimyosin Fab and technetium-99m-sestamibi in experimental nontransmural infarction. Morguet AJ; Munz DL; Klein HH; Pich S; Conrady A; Nebendahl K; Kreuzer H; Emrich D J Nucl Med; 1992 Feb; 33(2):223-8. PubMed ID: 1531070 [TBL] [Abstract][Full Text] [Related]
2. Transmural uptake of perfusion tracers and infarct-specific tracers. Johnson LL J Nucl Med; 1992 Feb; 33(2):229-30. PubMed ID: 1531071 [No Abstract] [Full Text] [Related]
3. [Simultaneous double nucleotide scintigraphy with indium 111 antimyosin Fab and technetium sestamibi for evaluation of myocardial viability after experimental and clinical infarct]. Morguet AJ; Munz DL; Kreuzer H; Emrich D Z Kardiol; 1996 Jun; 85(6):388-94. PubMed ID: 8767363 [TBL] [Abstract][Full Text] [Related]
4. Myocardial damage delineated by indium-111 antimyosin Fab and technetium-99m pyrophosphate. Khaw BA; Strauss HW; Moore R; Fallon JT; Yasuda T; Gold HK; Haber E J Nucl Med; 1987 Jan; 28(1):76-82. PubMed ID: 3025386 [TBL] [Abstract][Full Text] [Related]
5. Rapid infarct imaging with a technetium-99m-labeled antimyosin recombinant single-chain Fv: evaluation in a canine model of acute myocardial infarction. Nedelman MA; Shealy DJ; Boulin R; Brunt E; Seasholtz JI; Allen IE; McCartney JE; Warren FD; Oppermann H; Pang RH J Nucl Med; 1993 Feb; 34(2):234-41. PubMed ID: 8429342 [TBL] [Abstract][Full Text] [Related]
6. Comparative assessment of experimental myocardial infarction with 99Tcm-hexakis-t-butyl-isonitrile (sestamibi), 111In-antimyosin and 201Tl. Khaw BA; Mousa SA Nucl Med Commun; 1991 Oct; 12(10):853-63. PubMed ID: 1838801 [TBL] [Abstract][Full Text] [Related]
8. Myocardial distribution of indium-111-antimyosin Fab in acute inferior and right ventricular infarction: comparison with technetium-99m-pyrophosphate imaging and histologic examination. Nakata T; Sakakibara T; Noto T; Shoji T; Tsuda T; Kubota M; Hattori A; Iimura O J Nucl Med; 1991 May; 32(5):865-7. PubMed ID: 1850785 [TBL] [Abstract][Full Text] [Related]
9. Comparison of indium-111 antimyosin antibody and technetium-99m pyrophosphate localization in reperfused and nonreperfused myocardial infarction. Takeda K; LaFrance ND; Weisman HF; Wagner HN; Becker LC J Am Coll Cardiol; 1991 Feb; 17(2):519-26. PubMed ID: 1846888 [TBL] [Abstract][Full Text] [Related]
10. Acute myocardial infarct imaging with indium-111-labeled monoclonal antimyosin Fab. Khaw BA; Yasuda T; Gold HK; Leinbach RC; Johns JA; Kanke M; Barlai-Kovach M; Strauss HW; Haber E J Nucl Med; 1987 Nov; 28(11):1671-8. PubMed ID: 3668661 [TBL] [Abstract][Full Text] [Related]
11. [111In-antimyosin Fab scintigraphy in cardiovascular diseases: (multicenter clinical trial)]. Kawai C; Matsumori A; Nishimura T; Endo K Kaku Igaku; 1990 Dec; 27(12):1419-32. PubMed ID: 2290213 [TBL] [Abstract][Full Text] [Related]
12. An instant kit method for labeling antimyosin Fab' with technetium-99m: evaluation in an experimental myocardial infarct model. Pak KY; Nedelman MA; Kanke M; Khaw BA; Mattis JA; Strauss HW; Dean RT; Berger HJ J Nucl Med; 1992 Jan; 33(1):144-9. PubMed ID: 1730981 [TBL] [Abstract][Full Text] [Related]
13. Assessment of myocardial damage in dilated-phase hypertrophic cardiomyopathy by using indium-111-antimyosin Fab myocardial scintigraphy. Nishimura T; Nagata S; Uehara T; Hayashida K; Mitani I; Kumita S J Nucl Med; 1991 Jul; 32(7):1333-7. PubMed ID: 2066786 [TBL] [Abstract][Full Text] [Related]
14. Indium-111-antimyosin images compared with triphenyl tetrazolium chloride staining in a patient six days after myocardial infarction. Jain D; Crawley JC; Lahiri A; Raftery EB J Nucl Med; 1990 Feb; 31(2):231-3. PubMed ID: 1690274 [TBL] [Abstract][Full Text] [Related]
15. Immunoscintigraphy with 111In antimyosin Fab. Morguet AJ; Munz DL; Kreuzer H; Emrich D Nucl Med Commun; 1990 Nov; 11(11):727-35. PubMed ID: 2277688 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of myocardial infarct size before and after reperfusion: dual-tracer imaging with radiolabeled antimyosin antibody. Narula J; Nicol PD; Southern JF; Pieri P; O'Donnell SM; Guererro JL; Nossiff ND; Newell JB; Strauss HW; Khaw BA J Nucl Med; 1994 Jun; 35(6):1076-85. PubMed ID: 8195873 [TBL] [Abstract][Full Text] [Related]
17. Effect of reperfusion on 111In-antimyosin monoclonal antibody uptake by salvaged and necrotic myocardium in the dog. Merhi Y; Arsenault A; Carrier M; Latour JG Cardiovasc Res; 1993 Aug; 27(8):1504-9. PubMed ID: 8221805 [TBL] [Abstract][Full Text] [Related]
18. [Diagnosis of acute myocardial infarct using 2 new tracers: 111indium-labeled antimyosin antibodies and 99m-technetium isonitriles]. Righetti A; Ciaroni S; Podio V; Hügli V; Chevrolet JC Schweiz Med Wochenschr; 1989 Oct; 119(43):1514-8. PubMed ID: 2532783 [TBL] [Abstract][Full Text] [Related]
19. Imaging of cardiac transplantation rejection in primates using two new antimyosin agents. Vaccarino RA; Sanchez JE; Johnson LL; Wang TS; Seldin DW; Marboe C; Egbe P; Bhatia K; Rose EA; Khaw BA J Nucl Med; 1992 Nov; 33(11):1994-9. PubMed ID: 1432161 [TBL] [Abstract][Full Text] [Related]
20. (99m)Tc-annexin V and (111)In-antimyosin antibody uptake in experimental myocardial infarction in rats. Sarda-Mantel L; Michel JB; Rouzet F; Martet G; Louedec L; Vanderheyden JL; Hervatin F; Raguin O; Vrigneaud JM; Khaw BA; Le Guludec D Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):239-45. PubMed ID: 16283183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]